MYC and Burkitt lymphoma: BL/DLBCL is a genetically heterogeneous entity and, as noted in other series, not all patients have demonstrable c-Myc abnormalities.1 In our study, there were clinical differences between patients with BL/DLBCL and those with BL with respect to age, LDH, and bone marrow involvement.